Kerri Fitzgerald

DocwireNews

A study published in Blood observed an increased risk of arterial thromboembolic events&mdash;including myocardial infarction and stroke&mdash;5 months prior to a cancer diagnosis.Researchers assessed the Surveillance Epidemiology and End Results&ndash;Medicare dataset to identify 374,331 patients with cancer who were 67 years or older with a new primary diagnosis of breast, lung, prostate, colorectal, bladder, uterine, pancreatic, gastric cancer, or non-Hodgkin lymphoma between 2005 and 2013.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Patients with cancer are not only at higher risk of venous events: "Arterial thromboembolic events preceding the diagnosis of cancer in older persons" <a href="https://t.co/IBWVYOcRcK">https://t.co/IBWVYOcRcK</a> <a href="https://t.co/SZQNNV3JhZ">https://t.co/SZQNNV3JhZ</a>
&mdash; Scott Tagawa (@DrScottTagawa) <a href="https://twitter.com/DrScottTagawa/status/1076239836170858496?ref_src=twsrc%5Etfw">December 21, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Patients were then matched to individual controls without cancer based on year of birth, sex, race, and the presence of some other comorbidities, for a final participant total of 748,662.Researchers used the Mantel-Haenszel estimator to compare risks of arterial thromboembolic events between the cancer and non-cancer groups during 30-day periods in the 360 days before date of cancer diagnosis.From 360 to 151 days before cancer diagnosis, the 30-day interval risks of arterial thromboembolic events were similar between patients with cancer and matched controls. However, from 150 to 1 day before a cancer diagnosis, the interval 30-day risks of arterial thromboembolic events were higher in patients with cancer, and this progressively increased as the cancer diagnosis date approached, peaking during the 30-days immediately before cancer diagnosis.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
The risk of heart attack or stroke is increased by 70% in the 12 months and 500% in the 1 month before a cancer dx, highest in adults with lung and colorectal cancers and those with stage 3 or 4 disease. OMG! <a href="https://t.co/O0TLNEVg6P">https://t.co/O0TLNEVg6P</a>
&mdash; Craig Hofmeister (@EagleMyeloma) <a href="https://twitter.com/EagleMyeloma/status/1076137938726121475?ref_src=twsrc%5Etfw">December 21, 2018</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>At 30 days prior to diagnosis, the risk of developing an arterial thromboembolic event was more than 5.5-fold higher in the cancer cohort compared with the control group (P&lt;0.001). Specifically, 2,313 (0.62%) patients with cancer were diagnosed with an arterial thromboembolic event compared with 413 (0.11%) controls (odds ratio = 5.63; 95% CI, 5.07-6.25).During the 360 days prior to a cancer diagnosis, the risk of developing an arterial thromboembolic event was 69% higher among those who were later diagnosed with cancer compared with controls (1.75% vs 1.05%; P&lt;0.001).The highest risk of an arterial thromboembolic event in the 360 days preceding their diagnosis occurred in patients diagnosed with lung cancer, followed by colorectal cancer.<a href="https://proddocwire.wpengine.com/docwire-pick/vitamin-d-omega-3-cancer-heart-disease/">A new study says certain supplements do not prevent cancer or heart disease.</a><a href="https://proddocwire.wpengine.com/docwire-pick/night-shift-work-associated-with-risk-of-cancer-metabolic-disorders/">Night shift work is associated with a risk of cancer and metabolic disorders.</a>Source: <a href="http://www.bloodjournal.org/content/early/2018/12/20/blood-2018-06-860874?sso-checked=true">Blood</a>

MarkAlain Déry, DO

Eric Griggs, MD

Measles in America: An Ongoing Problem

Infectious Disease

Roger Rodby, MD

Joel M. Topf, MD, FACP

Seldin Award Winner Advocates Online Education

NKF Spring Clinical Meetings 2025

Hatem Soliman, MD

The Future of Dendritic Cell Vaccines in HER2+ Breast Cancer: Toward De-Escalation of Chemotherapy

HER2 Breast Cancer

Latest News

Study Observes an Increased Risk in Thromboembolic Events 30 Days Prior to Cancer Diagnosis

Oncology

A study published in Blood observed an increased risk of arterial thromboembolic events—including myocardial infarction and stroke—5 months prior to a cancer diagnosis. ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HR Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe